Stockreport

How The BioXcel Therapeutics (BTAI) Story Is Shifting With BXCL501 Hopes And Dilution Risks [Yahoo! Finance]

BioXcel Therapeutics, Inc.  (BTAI) 
Last bioxcel therapeutics, inc. earnings: 11/14 07:00 am Check Earnings Report
PDF The key shift in the BioXcel Therapeutics story right now sits in the range of Street price targets, with one cut from US$10 to US$6 while other targets extend into the [Read more]